Henry Anhalt
Technik-/Wissenschafts-/F&E-Leiter bei T1D Exchange
Profil
Dr. Henry Anhalt, MD, is Independent Director at Tandem Diabetes Care, Inc., Chief Medical Officer at T1D Exchange and Chief Medical Officer & Director-Medical Affairs at Animas Corp.
He is on the Board of Directors at Tandem Diabetes Care, Inc. He received his undergraduate degree from Yeshiva University.
Aktive Positionen von Henry Anhalt
| Unternehmen | Position | Beginn |
|---|---|---|
T1D Exchange
 T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2015 |
Ehemalige bekannte Positionen von Henry Anhalt
| Unternehmen | Position | Ende |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Direktor/Vorstandsmitglied | 05.04.2016 |
Animas LLC
 Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2012 |
Ausbildung von Henry Anhalt
| Yeshiva University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TANDEM DIABETES CARE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Health Technology |
